A qualitative exploration of patients' experience of mobile telephone-delivered contingency management to promote adherence to supervised methadone.
contingency management
opioid agonist treatment
opioids
remote delivery
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
08
08
2022
received:
05
05
2022
accepted:
07
09
2022
pubmed:
22
10
2022
medline:
23
3
2023
entrez:
21
10
2022
Statut:
ppublish
Résumé
Despite an increasing evidence base for mobile telephone-delivered contingency management (mCM), there had been no previous qualitative exploration of patients' experience of receiving mCM and the factors that might influence that experience and outcome in a UK setting. The aim of this study was to understand patients' views and experience of receiving mCM by exploring their beliefs, expectations and perceived benefits within the context of the UK's first mCM intervention. Qualitative interviews (N = 15) were conducted with patients undergoing opioid agonist treatment in a UK drug treatment service and receiving mCM to encourage adherence with supervised methadone as part of an existing study. Interviews were conducted at two time points and analysed using Framework to explore patients' expectations and beliefs during the early stage of the intervention (2 weeks) and their perceived benefits and experience at the end of the intervention (12 weeks). The mCM was perceived as a motivator, providing validation of achievement, and involving discreet and positive interactions. Perceived benefits included enhanced methadone adherence, reduced drug use and the development of a supportive and non-judgemental connection that resembled a therapeutic alliance. The mechanisms underpinning contingency management appeared to operate in the absence of human interaction, and the mCM intervention was deemed to be meaningful, acceptable and well received by patients. These findings not only provide support for the application of mCM in this context but also offer insight into the factors that influence outcomes and should be considered in the development of future mCM interventions.
Substances chimiques
Methadone
UC6VBE7V1Z
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
641-651Subventions
Organisme : Society for the Study of Addiction
Informations de copyright
© 2022 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
Références
Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101:1546-60.
Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101:192-203.
Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58:55-66.
Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L. Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev. 2016;5:CD005336.
Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, et al. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014;109:1426-36.
Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend. 1999;54:127-35.
DeFulio A, Everly JJ, Leoutsakos JMS, Umbricht A, Fingerhood M, Bigelow GE, et al. Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial. Drug Alcohol Depend. 2012;120:48-54.
Silverman K, Holtyn AF, Rodewald AM, Siliciano RF, Jarvis BP, Subramaniam S, et al. Incentives for viral suppression in people living with HIV: a randomized clinical trial. AIDS Behav. 2019;23:2337-46.
Weaver T, Metrebian N, Hellier J, Pilling S, Charles V, Little N, et al. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet. 2014;384:153-63.
Kidorf M, Brooner RK, Gandotra N, Antoine D, King VL, Peirce J, et al. Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial. Drug Alcohol Depend. 2013;133:30-6.
Schacht RL, Brooner RK, King VL, Kidorf MS, Peirce JM. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017;85:689-701.
Chen W, Hong Y, Zou X, McLaughlin MM, Xia Y, Ling L. Effectiveness of prize-based contingency management in a methadone maintenance program in China. Drug Alcohol Depend. 2013;133:270-4.
Metrebian N, Weaver T, Goldsmith K, Pilling S, Hellier J, Pickles A, et al. Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial. BMJ Open. 2021;11:e046371.
Dallery J, Raiff BR. Contingency management in the 21st century: technological innovations to promote smoking cessation. Subst Use Misuse. 2011;46:10-22.
DeFulio A. Dissemination of contingency management for the treatment of opioid use disorder. Perspect Behav Sci. 2022;1-15. https://doi.org/10.1007/s40614-022-00328-z
Getty CA, Morande A, Lynskey M, Weaver T, Metrebian N. Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis. Addiction. 2019;114:1915-25.
DeFulio A, Rzeszutek MJ, Furgeson J, Ryan S, Rezania S. A smartphone-smartcard platform for contingency management in an inner-city substance use disorder outpatient program. J Subst Abus Treat. 2020;120:108188.
Getty CA, Weaver T, Lynskey M, Kirby KC, Dallery J, Metrebian N. Patients' beliefs towards contingency management: target behaviours, incentives and the remote application of these interventions. Drug Alcohol Rev. 2022;41:96-105.
DeFulio A, Devoto A, Traxler H, Cosottile D, Fingerhood M, Nuzzo P, et al. Smartphone-based incentives for promoting adherence to antiretroviral therapy: a randomized controlled trial. Prev Med Rep. 2021;21:101318.
Hertzberg JS, Carpenter VL, Kirby AC, Calhoun PS, Moore SD, Dennis MF, et al. Mobile contingency management as an adjunctive smoking cessation treatment for smokers with posttraumatic stress disorder. Nicotine Tob Res. 2013;15:1934-8.
Kong G, Goldberg AL, Dallery J, Krishnan-Sarin S. An open-label pilot study of an intervention using mobile phones to deliver contingency management of tobacco abstinence to high school students. Exp Clin Psychopharmacol. 2017;25:333-7.
Beckham JC, Adkisson KA, Hertzberg J, Kimbrel NA, Budney AJ, Stephens RS, et al. Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking. Addict Behav. 2018;79:86-92.
Metrebian N, Carr E, Goldsmith K, Weaver T, Pilling S, Shearer J, et al. Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES). Pilot Feasibility Stud. 2021;7:14.
Hammond AS, Sweeney MM, Chikosi TU, Stitzer ML. Digital delivery of a contingency management intervention for substance use disorder: a feasibility study with DynamiCare Health. J Subst Abus Treat. 2021;126:108425.
Neale J, Tompkins CN, Strang J. Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment. Addiction. 2016;111:665-74.
Henson P, Peck P, Torous J. Considering the therapeutic alliance in digital mental health interventions. Harv Rev Psychiatry. 2019;27:268-73.
Day E, Mitcheson L. Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism? Addiction. 2017;112:1329-36.
Horvath AO, Symonds BD. Relation between working alliance and outcome in psychotherapy: a meta-analysis. J Couns Psychol. 1991;38:139-49.
Cavanagh K, Millings A. (Inter) personal computing: the role of the therapeutic relationship in e-mental health. J Contemp Psychother. 2013;43:197-206.
Kiluk BD, Serafini K, Frankforter T, Nich C, Carroll KM. Only connect: the working alliance in computer-based cognitive behavioral therapy. Behav Res Ther. 2014;63:139-46.
Strang J, Group IEW. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health and Social Care, UK gov; 2017.
Ritchie J, Spencer L. Qualitative data analysis for applied policy research. Analyzing qualitative data. London: Routledge; 2002. p. 187-208.
Neale J. Iterative categorization (IC): a systematic technique for analysing qualitative data. Addiction. 2016;111:1096-106.
Stone E, Fletcher K. User views on supervised methadone consumption. Addict Biol. 2003;8:45-8.
Anstice S, Strike CJ, Brands B. Supervised methadone consumption: client issues and stigma. Subst Use Misuse. 2009;44:794-808.
Woo J, Bhalerao A, Bawor M, Bhatt M, Dennis B, Mouravska N, et al. “Don't judge a book by its cover”: a qualitative study of methadone patients' experiences of stigma. Subst Abus. 2017;11:1178221816685087.
DeFulio A, Brown HD, Davidson RM, Regnier SD, Kang N, Ehart M. Feasibility, acceptability, and preliminary efficacy of a smartphone-based contingency management intervention for buprenorphine adherence. Behav Anal Pract. 2022;15:1-9.
Mayock P, Butler S. “I'm always hiding and ducking and diving”: the stigma of growing older on methadone. Drugs Educ Prev Policy. 2022;29:139-49.
Rash CJ, Petry NM, Kirby KC, Martino S, Roll J, Stitzer ML. Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend. 2012;121:205-12.
Horvath AO, Del Re AC, Flückiger C, Symonds D. Alliance in individual psychotherapy. Psychotherapy (Chic). 2011;48(1):9-16.
Clarke J, Proudfoot J, Whitton A, Birch MR, Boyd M, Parker G, et al. Therapeutic alliance with a fully automated mobile phone and web-based intervention: secondary analysis of a randomized controlled trial. JMIR Ment Health. 2016;3:e10.
Ormrod JA, Kennedy L, Scott J, Cavanagh K. Computerised cognitive behavioural therapy in an adult mental health service: a pilot study of outcomes and alliance. Cogn Behav Ther. 2010;39:188-92.
Berry K, Salter A, Morris R, James S, Bucci S. Assessing therapeutic alliance in the context of mHealth interventions for mental health problems: development of the mobile Agnew relationship measure (mARM) questionnaire. J Med Internet Res. 2018;20:e8252.